Scripps VIVO scripps research logo

  • Index
  • Log in
  • Home
  • People
  • Organizations
  • Research
  • Events
Search form
As of April 1st VIVO Scientific Profiles will no longer updated for faculty, and the link to VIVO will be removed from the library website. Faculty profile pages will continue to be updated via Interfolio. VIVO will continue being used behind the scenes to update graduate student profiles. Please contact helplib@scripps.edu if you have questions.
How to download citations from VIVO | Alternative profile options

Retroviruses pseudotyped with the severe acute respiratory syndrome coronavirus spike protein efficiently infect cells expressing angiotensin-converting enzyme 2

Academic Article
uri icon
  • Overview
  • Identity
  • Additional Document Info
  • View All
scroll to property group menus

Overview

authors

  • Moore, M. J.
  • Dorfman, T.
  • Li, W. H.
  • Wong, S. K.
  • Li, Yuxing
  • Kuhn, J. H.
  • Coderre, J.
  • Vasilieva, N.
  • Han, Z. C.
  • Greenough, T. C.
  • Farzan, Michael
  • Choe, Hyeryun

publication date

  • October 2004

journal

  • Journal of Virology  Journal

abstract

  • Infection of receptor-bearing cells by coronaviruses is mediated by their spike (S) proteins. The coronavirus (SARS-CoV) that causes severe acute respiratory syndrome (SARS) infects cells expressing the receptor angiotensin-converting enzyme 2 (ACE2). Here we show that codon optimization of the SARS-CoV S-protein gene substantially enhanced S-protein expression. We also found that two retroviruses, simian immunodeficiency virus (SIV) and murine leukemia virus, both expressing green fluorescent protein and pseudotyped with SARS-CoV S protein or S-protein variants, efficiently infected HEK293T cells stably expressing ACE2. Infection mediated by an S-protein variant whose cytoplasmic domain had been truncated and altered to include a fragment of the cytoplasmic tail of the human immunodeficiency virus type 1 envelope glycoprotein was, in both cases, substantially more efficient than that mediated by wild-type S protein. Using S-protein-pseudotyped SIV, we found that the enzymatic activity of ACE2 made no contribution to S-protein-mediated infection. Finally, we show that a soluble and catalytically inactive form of ACE2 potently blocked infection by S-protein-pseudotyped retrovirus and by SARS-CoV. These results permit studies of SARS-CoV entry inhibitors without the use of live virus and suggest a candidate therapy for SARS.

subject areas

  • Amino Acid Sequence
  • Animals
  • Carboxypeptidases
  • Cell Line
  • HIV-1
  • Humans
  • Leukemia Virus, Murine
  • Membrane Glycoproteins
  • Molecular Sequence Data
  • Peptidyl-Dipeptidase A
  • Receptors, Virus
  • SARS Virus
  • Simian Immunodeficiency Virus
  • Spike Glycoprotein, Coronavirus
  • Viral Envelope Proteins
  • Virion
  • Virus Replication
scroll to property group menus

Identity

PubMed Central ID

  • PMC516384

International Standard Serial Number (ISSN)

  • 0022-538X

Digital Object Identifier (DOI)

  • 10.1128/jvi.78.19.10628-10635.2004

PubMed ID

  • 15367630
scroll to property group menus

Additional Document Info

start page

  • 10628

end page

  • 10635

volume

  • 78

issue

  • 19

©2022 The Scripps Research Institute | Terms of Use | Powered by VIVO

  • About
  • Contact Us
  • Support